Will Weakness in KPJ Healthcare Berhad's (KLSE:KPJ) Stock Prove Temporary Given Strong Fundamentals?
ROE or return on equity is a useful tool to assess how effectively a company can generate returns on the investment it received from its shareholders. Put another way, it reveals the company's success at turning shareholder investments into profits.
This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.
Return on equity can be calculated by using the formula:
Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity
So, based on the above formula, the ROE for KPJ Healthcare Berhad is:
13% = RM370m ÷ RM2.8b (Based on the trailing twelve months to March 2025).
The 'return' is the amount earned after tax over the last twelve months. So, this means that for every MYR1 of its shareholder's investments, the company generates a profit of MYR0.13.
Check out our latest analysis for KPJ Healthcare Berhad
So far, we've learned that ROE is a measure of a company's profitability. Depending on how much of these profits the company reinvests or "retains", and how effectively it does so, we are then able to assess a company's earnings growth potential. Assuming everything else remains unchanged, the higher the ROE and profit retention, the higher the growth rate of a company compared to companies that don't necessarily bear these characteristics.
To start with, KPJ Healthcare Berhad's ROE looks acceptable. Further, the company's ROE compares quite favorably to the industry average of 9.2%. This probably laid the ground for KPJ Healthcare Berhad's significant 25% net income growth seen over the past five years. We believe that there might also be other aspects that are positively influencing the company's earnings growth. For example, it is possible that the company's management has made some good strategic decisions, or that the company has a low payout ratio.
As a next step, we compared KPJ Healthcare Berhad's net income growth with the industry, and pleasingly, we found that the growth seen by the company is higher than the average industry growth of 15%.
The basis for attaching value to a company is, to a great extent, tied to its earnings growth. What investors need to determine next is if the expected earnings growth, or the lack of it, is already built into the share price. Doing so will help them establish if the stock's future looks promising or ominous. What is KPJ worth today? The intrinsic value infographic in our free research report helps visualize whether KPJ is currently mispriced by the market.
The high three-year median payout ratio of 51% (implying that it keeps only 49% of profits) for KPJ Healthcare Berhad suggests that the company's growth wasn't really hampered despite it returning most of the earnings to its shareholders.
Moreover, KPJ Healthcare Berhad is determined to keep sharing its profits with shareholders which we infer from its long history of paying a dividend for at least ten years. Based on the latest analysts' estimates, we found that the company's future payout ratio over the next three years is expected to hold steady at 51%. Accordingly, forecasts suggest that KPJ Healthcare Berhad's future ROE will be 15% which is again, similar to the current ROE.
Overall, we are quite pleased with KPJ Healthcare Berhad's performance. Especially the high ROE, Which has contributed to the impressive growth seen in earnings. Despite the company reinvesting only a small portion of its profits, it still has managed to grow its earnings so that is appreciable. Having said that, the company's earnings growth is expected to slow down, as forecasted in the current analyst estimates. Are these analysts expectations based on the broad expectations for the industry, or on the company's fundamentals? Click here to be taken to our analyst's forecasts page for the company.
—
Investing narratives with Fair Values
Suncorp's Next Chapter: Insurance-Only and Ready to Grow By Robbo – Community Contributor
Fair Value Estimated: A$22.83 · 0.1% Overvalued
Thyssenkrupp Nucera Will Achieve Double-Digit Profits by 2030 Boosted by Hydrogen Growth By Chris1 – Community Contributor
Fair Value Estimated: €14.40 · 0.3% Overvalued
Tesla's Nvidia Moment – The AI & Robotics Inflection Point By BlackGoat – Community Contributor
Fair Value Estimated: $384.84 · 0.2% Overvalued
View more featured narratives
—
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
National Vision (EYE) Q2 Earnings: What To Expect
Optical retailer National Vision (NYSE:EYE) will be reporting earnings this Wednesday before the bell. Here's what investors should know. National Vision beat analysts' revenue expectations by 1.5% last quarter, reporting revenues of $510.3 million, up 5.7% year on year. It was a very strong quarter for the company, with full-year EPS guidance exceeding analysts' expectations and a solid beat of analysts' EBITDA estimates. Is National Vision a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting National Vision's revenue to grow 4% year on year to $469.8 million, in line with the 4.6% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.14 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. National Vision has missed Wall Street's revenue estimates five times over the last two years. Looking at National Vision's peers in the consumer retail segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Tractor Supply delivered year-on-year revenue growth of 4.5%, beating analysts' expectations by 0.9%, and Walgreens reported revenues up 7.2%, topping estimates by 6.4%. Tractor Supply's stock price was unchanged after the resultswhile Walgreens was up 1.2%. Read our full analysis of Tractor Supply's results here and Walgreens's results here. Investors in the consumer retail segment have had steady hands going into earnings, with share prices flat over the last month. National Vision is up 9.3% during the same time and is heading into earnings with an average analyst price target of $27 (compared to the current share price of $25.50). Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Stock Screening Made Simple: A Closer Look
Stock screening is commonly deployed by investors to 'cut through the noise.' The approach is especially useful when considering the thousands of options to choose from, which can often overwhelm investors. Screening is essentially the same idea as constructing a grocery list. A list helps you easily navigate a store, allowing you to quickly find what you're looking for without wasting a chunk of time. But it an quickly become overwhelming, particularly when investors are unsure what to look. In addition, it's not as simple as a one-screen-fits-all approach, as investors all have different preferences. Let's take a closer look at screening and a few parameters available at Zacks that investors can deploy to find the stocks that they want. Screening Parameters Parameters can be seen as the 'ingredients' of a recipe, excluding any irrelevant information. Digging deeper, parameters can be fine-tuned for any investing style, whether that be momentum, value, growth, or income-based. Value Investing Value investors can add several parameters to their screens to find high-quality stocks trading at a discount. A few of these include the Price-to-Earnings (P/E) ratio, the Price-to-Sales (P/S) ratio, and the Price-to-Book (P/B) ratio. Zacks has several premium screens tailored toward value-focused strategies that have these parameters built in. Momentum Investing Momentum investing is all about riding the current trend, jumping into stocks that have enjoyed buying pressure. A few parameters investors can deploy for momentum-focused screens include the percentage price change in the stock over the last month, average volume, and price as a percentage of the 52-week high-low range. Zacks has many momentum-based screens with these parameters built in. Growth Investing Growth-oriented strategies are aimed at companies expected to grow their sales and earnings at an above-average level, a development that commonly leads to share outperformance. A few key parameters for growth investors include last year's earnings and sales growth rates, expected growth rates for the current year, and the long-term expected EPS growth rate. One of the Zacks premium growth screens provided us with a few stocks upon running: Credo Technology CRDO and Robinhood Markets HOOD, two great examples of companies that have enjoyed rapid growth. Credo Technology has benefited from the AI frenzy, with CRDO's results regularly highlighting strong demand. Robinhood Markets has enjoyed serious user growth, also reflected in HOOD's quarterly releases. Income Investing Income-focused investing is all about passive income, with dividend-paying stocks commonly being more 'stable.' Many dividend-paying companies are mature and, at the end of their growth cycle, opting to share profits with shareholders rather than reinvesting for the future. A few parameters investors can deploy when searching for dividend-paying stocks include current dividend yield and the 5-year historical dividend growth rate. No different than those above, Zacks already has several premium income-focused screens available for use. Bottom Line Screens are very useful tools for investors to filter out the noise, allowing for full focus on preferred parameters. The process can often be overwhelming, though, with some unsure of what parameters to include. However, for those not interested in building out an individual screen, Zacks has many pre-built screens tailored toward common strategies, a list that includes growth, value, momentum, and income. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Robinhood Markets, Inc. (HOOD) : Free Stock Analysis Report Credo Technology Group Holding Ltd. (CRDO) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Why Netflix Stock Lost 13% in July
Key Points Netflix declined steadily over the month due to valuation-related fears. The company delivered a strong second-quarter earnings report, but it wasn't enough to lift the stock. The stock still looks like a buy over the long term. 10 stocks we like better than Netflix › Netflix (NASDAQ: NFLX) has been one of the top-performing stocks in the market over the last few years, but that blistering growth seemed to catch up with it in July, as a strong second-quarter earnings report wasn't enough to push the stock higher. Instead, investors bailed on the stock as valuation concerns seemed to override another round of solid growth. According to data from S&P Global Market Intelligence, the streaming stock finished the month down 13%. As you can see from the chart, the stock headed lower over much of July, even as the S&P 500 (SNPINDEX: ^GSPC) finished with a 2.2% gain. Netflix takes a step back Netflix's pullback last month showcases what happens when a stock is priced to perfection. The stock was already falling heading into the second-quarter report, even though there was no major news out on the company. When it came time for its update, Netflix delivered strong numbers. Revenue rose 16% to $11.08 billion, narrowly topping expectations at $11.04 billion. Netflix no longer reports quarterly subscriber growth, but its growth was broad-based across all four of its regions, with currency-neutral revenue growth of 15% or better in each territory. On the bottom line, its operating margin jumped from 27.2% in the quarter a year ago to 34.1%, and it reported earnings per share of $7.19, up from $4.88 in the quarter a year ago and better than the consensus at $7.06. The company also raised its guidance for the year, upping its revenue forecast from $43.5 billion-$44.5 billion to $44.8 billion-$45.8 billion and its operating margin from 29% to 29.5%. However, that was not enough to push the stock higher, as pressure from valuation and high expectations leading into the report seemed to have overcome the "beat and raise" results. Is Netflix a buy after the pullback? Netflix is now trading at a price-to-earnings ratio of 50, which is expensive, even for a growth stock. However, its recent push into advertising is paying off, and its local content strategy is driving growth around the world. Its subscription model should also drive profit margins higher as its subscriber base continues to grow. In the near future, valuation pressure could push the stock lower, but over the longer term, its leadership in streaming and broader growth tailwinds should make the stock a winner. Should you buy stock in Netflix right now? Before you buy stock in Netflix, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Netflix wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $624,823!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,064,820!* Now, it's worth noting Stock Advisor's total average return is 1,019% — a market-crushing outperformance compared to 178% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 4, 2025 Jeremy Bowman has positions in Netflix. The Motley Fool has positions in and recommends Netflix. The Motley Fool has a disclosure policy. Why Netflix Stock Lost 13% in July was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
